Andorra vs Iceland: New or unknown treatment history cases: Pulmonary, bacteriologically
Andorra
4
in 2023
Iceland
8
in 2022
Andorra rank
186th
Iceland rank
183rd
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Andorra
- Iceland
How they compare
Iceland currently reports 8 against 4 in Andorra, a difference of 4.
That makes Iceland's figure about 2.0 times Andorra's.
The two have swapped places 10 times across 21 shared years of data; in 2002 it was Iceland ahead.
Andorra ranks 186th and Iceland ranks 183rd of 197 countries.
Across the 3 decades both report, Andorra averaged higher in 1 and Iceland in 2.
Head to head by decade
| Decade | Andorra | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.62 | 4.38 | 0.25 | Andorra |
| 2010s | 2.8 | 5 | 2.2 | Iceland |
| 2020s | 2.33 | 6 | 3.67 | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Andorra or Iceland?
- Iceland, at 8 against 4 in Andorra as of 2022.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Andorra and Iceland?
- 4, with Iceland ahead.
- How many years of comparable data are there for Andorra and Iceland?
- 21 years are reported by both, from 2002 to 2022.
- How do Andorra and Iceland rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Andorra ranks 186th and Iceland ranks 183rd of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.